Intradermal immunization triggers epidermal langerhans cell mobilization required for CD8 T-cell immune responses

Journal of Investigative Dermatology

Volumn 132, Issue 3 PART 1, 2012, Pages 615-625

  Liard, Christelle ^a   Munier, Séverine ^b   Joulin Giet, Alix ^a   Bonduelle, Olivia ^a   Hadam, Sabrina ^c   Duffy, Darragh ^a   Vogt, Annika ^c   Verrier, Bernard ^b   Combadière, Béhazine ^a  

^a INSERM   (France)

^b INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MODIFIED VACCINIA VIRUS ANKARA VACCINE; NANOPARTICLE; NEUTRALIZING ANTIBODY; POLY DEXTRO LYSINE; POLYLACTIC ACID; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DENSITY; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; EXPLANT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNIZATION; LANGERHANS CELL; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 84857063520     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.346     Document Type: Article

References (51)

1. Abadie V, Badell E, Douillard P et al. (2005) Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. Blood 106:1843-50 (Pubitemid 41208603)
2. Abadie V, Bonduelle O, Duffy D et al. (2009) Original encounter with antigen determines antigen-presenting cell imprinting of the quality of the immune response in mice. PLoS One 4:e8159
3. Allan RS, Smith CM, Belz GT et al. (2003) Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 301:1925-8 (Pubitemid 37229056)
4. Allan RS, Waithman J, Bedoui S et al. (2006) Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25:153-62 (Pubitemid 44066832)
5. Bedoui S, Whitney PG, Waithman J et al. (2009) Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol 10:488-95
6. Belshe RB (2007) The burden of influenza and strategies for prevention. Manag Care 16:2-6
7. Bennett CL, Noordegraaf M, Martina CA et al. (2007) Langerhans cells are required for efficient presentation of topically applied hapten to T cells. J Immunol 179:6830-5
8. Bursch LS, Wang L, Igyarto B et al. (2007) Identification of a novel population of Langerin+ dendritic cells. J Exp Med 204:3147-56
9. Caux C, Massacrier C, Vanbervliet B et al. (1997) CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood 90:1458-70 (Pubitemid 27355417)
10. Charest AF, McDougall J, Goldstein MB (2000) A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 36: 976-82
11. Combadiere B, Vogt A, Mahe B et al. (2010) Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: A randomized phase I trial. PLoS One 5:e10818
12. Cunningham AL, Abendroth A, Jones C et al. (2010) Viruses and Langerhans cells. Immunol Cell Biol 88:416-23
13. Egemen A, Aksit S, Kurugol Z et al. (1998) Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: A comparison of immunogenicity in infants and preschool children. Vaccine 16:1511-5 (Pubitemid 28370049)
14. Elnekave M, Furmanov K, Nudel I et al. (2010) Directly transfected langerin+ dermal dendritic cells potentiate CD8+ T cell responses following intradermal plasmid DNA immunization. J Immunol 185:3463-71
15. Fay JW, Palucka AK, Paczesny S et al. (2006) Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptidepulsed CD34(+) progenitor-derived dendritic cells. Cancer Immunol Immunother 55:1209-18 (Pubitemid 43992047)
16. Frech SA, Kenney RT, Spyr CA et al. (2005) Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine 23:946-50 (Pubitemid 39643184)
17. Furmanov K, Elnekave M, Lehmann D et al. (2010) The role of skin-derived dendritic cells in CD8+ T cell priming following immunization with lentivectors. J Immunol 184:4889-97
18. Gervaz E, Dauge-Geffroy MD, Sobhani I et al. (1995) Quantitative analysis of the immune cells in the anal mucosa. Pathol Res Pract 191:1067-71 (Pubitemid 26031750)
19. Ginhoux F, Collin MP, Bogunovic M et al. (2007) Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J Exp Med 204:3133-46
20. Ginhoux F, Tacke F, Angeli V et al. (2006) Langerhans cells arise from monocytes in vivo. Nat Immunol 7:265-73
21. Henderson EA, Louie TJ, Ramotar K et al. (2000) Comparison of higher-dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers. Infect Control Hosp Epidemiol 21:264-9
22. Honda T, Miyachi Y, Kabashima K (2010) The role of regulatory T cells in contact hypersensitivity. Recent Pat Inflamm Allergy Drug Discov 4:85-9
23. Kaplan DH, Jenison MC, Saeland S et al. (2005) Epidermal langerhans celldeficient mice develop enhanced contact hypersensitivity. Immunity 23:611-20 (Pubitemid 41779483)
24. Kissenpfennig A, Henri S, Dubois B et al. (2005) Dynamics and function of Langerhans cells in vivo: Dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22:643-54 (Pubitemid 40719199)
25. Kitano Y, Okada N (1983) Separation of the epidermal sheet by dispase. Br J Dermatol 108:555-60 (Pubitemid 13072933)
26. Klechevsky E, Morita R, Liu M et al. (2008) Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29:497-510
27. Kupper TS, Fuhlbrigge RC (2004) Immune surveillance in the skin: Mechanisms and clinical consequences. Nat Rev Immunol 4:211-22 (Pubitemid 38339087)
28. Lamalle-Bernard D, Munier S, Compagnon C et al. (2006) Coadsorption of HIV-1 p24 and gp120 proteins to surfactant-free anionic PLA nanoparticles preserves antigenicity and immunogenicity. J Control Release 115:57-67 (Pubitemid 44429985)
29. Lambert PH, Laurent PE (2008) Intradermal vaccine delivery: Will new delivery systems transform vaccine administration? Vaccine 26:3197-208
30. Mahe B, Vogt A, Liard C et al. (2009) Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. J Invest Dermatol 129:1156-64
31. Merad M, Ginhoux F, Collin M (2008) Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 8:935-47
32. Merad M, Hoffmann P, Ranheim E et al. (2004) Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med 10:510-7 (Pubitemid 38667910)
33. Merad M, Manz MG, Karsunky H et al. (2002) Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 3:1135-41 (Pubitemid 35469697)
34. Nicolas JF, Guy B (2008) Intradermal, epidermal and transcutaneous vaccination: From immunology to clinical practice. Expert Rev Vaccines 7:1201-14
35. Noordegraaf M, Flacher V, Stoitzner P et al. (2010) Functional redundancy of Langerhans cells and Langerin+ dermal dendritic cells in contact hypersensitivity. J Invest Dermatol 130:2752-9
36. Nudel I, Elnekave M, Furmanov K et al. (2011) Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells. J Immunol 186:891-900
37. Pearton M, Kang SM, Song JM et al. (2010) Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines. PLoS One 5:e12410
38. Primard C, Rochereau N, Luciani E et al. (2010) Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells. Biomaterials 31:6060-8
39. Ratzinger G, Baggers J, de Cos MA et al. (2004) Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells. J Immunol 173:2780-91 (Pubitemid 39063140)
40. Romani N, Clausen BE, Stoitzner P (2010a) Langerhans cells and more: Langerin-expressing dendritic cell subsets in the skin. Immunol Rev 234:120-41
41. Romani N, Thurnher M, Idoyaga J et al. (2010b) Targeting of antigens to skin dendritic cells: Possibilities to enhance vaccine efficacy. Immunol Cell Biol 88:424-30
42. Sabchareon A, Chantavanich P, Pasuralertsakul S et al. (1998) Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine. Pediatr Infect Dis J 17:1001-7 (Pubitemid 28549419)
43. Stoecklinger A, Eticha TD, Mesdaghi M et al. (2011) Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH gamma-1 class switching in response to gene gun vaccines. J Immunol 186:1377-83
44. Stoitzner P, Green LK, Jung JY et al. (2008) Tumor immunotherapy by epicutaneous immunization requires langerhans cells. J Immunol 180:1991-8
45. Sumida SM, McKay PF, Truitt DM et al. (2004) Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. J Clin Invest 114:1334-42 (Pubitemid 40385305)
46. Ueno H, Palucka AK, Banchereau J (2010a) The expanding family of dendritic cell subsets. Nat Biotechnol 28:813-5
47. Ueno H, Schmitt N, Klechevsky E et al. (2010b) Harnessing human dendritic cell subsets for medicine. Immunol Rev 234:199-212
48. Vesely DL, Fish D, Shlomchik MJ et al. (2009) Langerhans cell deficiency impairs Ixodes scapularis suppression of Th1 responses in mice. Infect Immun 77:1881-7
49. Vien NC, Feroldi E, Lang J (2008) Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children. Trans R Soc Trop Med Hyg 102:294-6
50. Vogt A, Combadiere B, Hadam S et al. (2006) 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol 126:1316-22 (Pubitemid 43997914)
51. Vogt A, Mahe B, Costagliola D et al. (2008) Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans. J Immunol 180:1482-9